Research Project

Project Title:	A Study Evaluating the Efficacy and Safety of Obinutuzumab in Participants With Primary Membranous Nephropathy (MAJESTY)
Project Type:	Clinical Trial, Enrolment ongoing
Disease group(s):	Immune glomerulopathies
Project Summary:	A Study Evaluating the Efficacy and Safety of Obinutuzumab in Participants With Primary Membranous Nephropathy (MAJESTY).
Lead principal investigator(s):	Loreto Gesualdo, Bari
Co-investigator(s):	Marica Giliberti, Bari
Project Period:	06/2021 - 12/2027
Sponsors:	Industry
ClinicalTrials.gov:	NCT04629248